Significados de induce ligand en inglés

The tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) pathway transmits apoptotic signals.

Resistance to tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) is a major limitation for its clinical use.

Here we describe a novel member of the TNF family designated APRIL (for a proliferation- inducing ligand).

A proliferation- inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in tumor cell proliferation.

Background: Tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) induces apoptosis in malignant cells but not in normal cells.

Purpose: B-lymphocyte stimulator and a proliferation- inducing ligand regulate B-cell homeostasis and immunoglobulin production and are overexpressed in B-cell malignancies.

Tumor necrosis factor-related apoptosis induced ligand (TRAIL) is an important apoptosis inducer in a variety of tumor cells.

ER stress induces the upregulation of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor and opening new horizons for therapeutic research.

TNF-related apoptosis- inducing ligand (TRAIL) is a type II integral membrane protein that interacts with multiple receptors and cell types including neurons.

In addition, overexpression of RTVP-1 rendered glioma cells more resistant to the apoptotic effect of tumor necrosis factor-related apoptosis- inducing ligand and serum deprivation.

Here we show that tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) plays a critical role in the NK cell-mediated and IFN-gamma-dependent tumor surveillance.

We have previously reported tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) immunoreactivity within pulmonary vascular lesions from patients with idiopathic PAH and animal models.

One such anti-neoplastic protein is tumour necrosis factor-related apoptosis- inducing ligand (TRAIL) because it induces apoptosis in cancerous cells, but not in non-transformed cells.

Tumor necrosis factor-related apoptosis- inducing ligand (TRAIL), a tumor necrosis factor superfamily member, targets death receptors and selectively kills malignant cells while leaving normal cells unaffected.